WallStreetZenWallStreetZen

NASDAQ: JAZZ
Jazz Pharmaceuticals PLC Stock Ownership - Who owns Jazz Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Jazz Pharmaceuticals PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Neena M. PatilCLO;EVP2026-09-101,200$240.94
$289.13kSell
Mary Elizabeth HendersonSVP2026-09-081,412$243.03
$343.16kSell
Renee D. GalaCEO;Pres2026-09-082,000$243.03
$486.06kSell
Renee D. GalaCEO;Pres2026-09-081,967$246.81
$485.48kSell
Mary Elizabeth HendersonSVP2026-09-0815$241.20
$3.62kSell
Bruce C. CozaddDirector2026-09-016,000$250.13
$1.50MSell
Norbert G. RiedelDirector2026-08-3114$244.64
$3.43kSell
Jennifer E. CookDirector2026-08-3114$244.06
$3.42kSell
Jennifer E. CookDirector2026-08-311,692$241.39
$408.43kSell
Heather Ann McSharryDirector2026-08-311,840$241.39
$444.16kSell

1 of 13

JAZZ insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when JAZZ insiders and whales buy or sell their stock.

JAZZ Shareholders

What type of owners hold Jazz Pharmaceuticals PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kkr Group Partnership LP47.11%30,583,176$7.45BInsider
Kkr Jp III LLC30.93%20,078,838$4.89BInsider
Michael W. Michelson28.61%18,571,250$4.52BInsider
Paul E. Raether28.59%18,557,365$4.52BInsider
Kkr Jp LLC28.59%18,557,365$4.52BInsider
Kkr Group Holdings LP15.32%9,942,946$2.42BInsider
William J. Janetschek13.21%8,577,974$2.09BInsider
Kenneth W. Okeefe9.97%6,469,439$1.58BInsider
Bryan C. Cressey9.08%5,894,549$1.44BInsider
Samuel D. Colella6.61%4,291,367$1.05BInsider

1 of 3

JAZZ vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
JAZZ0.04%99.96%Net SellingNet Selling
ASND0.10%0.78%Net SellingNet Buying
EXEL0.10%5.67%Net SellingNet Selling
SMMT0.01%99.99%Net Buying
BBIO0.10%56.78%Net SellingNet Selling
View Top Biotech Stocks

Jazz Pharmaceuticals Stock Ownership FAQ

Who owns Jazz Pharmaceuticals?

Jazz Pharmaceuticals (NASDAQ: JAZZ) is owned by 0.10% institutional shareholders, 235.07% Jazz Pharmaceuticals insiders, and 0.00% retail investors. Kkr Group Partnership LP is the largest individual Jazz Pharmaceuticals shareholder, owning 30.58M shares representing 47.11% of the company. Kkr Group Partnership LP's Jazz Pharmaceuticals shares are currently valued at $7.46B.

If you're new to stock investing, here's how to buy Jazz Pharmaceuticals stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.